US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Salento Organics Issues Allergy Alert on Undeclared Milk in Dark Chocolate Fruit and Peanut Bites

      Summary Company Announcement Date: March 29, 2023 FDA Publish Date: … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Food Recalls / FDA Press Releases / Aurobindo Pharma Limited Issues Voluntary Recall of Irbesartan Drug Substance due to the Detection of Trace Amounts of NDEA (NNitrosodiethylamine) Impurity Found in the Active Pharmaceutical Ingredient (API)

Aurobindo Pharma Limited Issues Voluntary Recall of Irbesartan Drug Substance due to the Detection of Trace Amounts of NDEA (NNitrosodiethylamine) Impurity Found in the Active Pharmaceutical Ingredient (API)

October 29, 2018 By The FDA Leave a Comment

Aurobindo Pharma Limited is voluntarily recalling 22 Batches of the drug substance Irbesartan due to the presence of an impurity, N-nitrosodiethylamine (NDEA). The impurity, which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC).

These 22 batches of Irbesartan drug substance were supplied to ScieGen Pharmaceuticals Inc., U.S. for the manufacturing of finished Irbesartan drug product (see attached annexure).

Aurobindo Pharma Limited has notified ScieGen Pharmaceuticals, Inc. of the recall and is arranging for the return of all available Irbesartan drug substance. Aurobindo Pharma Limited has further advised Sciegen Pharmaceuticals, Inc. to contact its distributors and retailers to return Irbesartan drug product and finished Irbesartan tablets that has been identified by Aurobindo Pharma Limited.

Patients should contact their pharmacist or physician who can advise them about an alternative treatment prior to returning their medication. Patients who are on Irbesartan should continue taking their medication, as the risk of harm to a patient’s health may be higher if the treatment is stopped immediately without any alternative treatment. Patients should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using Irbesartan.

Adverse reactions or quality problems associated with the use of this product may be reported to FDA’s MedWatch Adverse Event Reporting program either by phone, on line, by regular mail or by fax.

 Annexure -I
Irbesartan batches Supplied to US Customers

S.No Manufacturing Batch Number Dispatch Batch Number Date of Manufacture Date of Distribution Retest/Expiry Date Dispatch Qty Name and Location of the Customer NDEA Impurity Result ug/g
1 1601100782 1601101589 Jan-2016 Jan-2016 Dec-2016 90.29 Kg Sciegen Pharmaceuticals INC, USA 0.23
2 1601100783 1601101590 Jan-2016 3l-Jan-2016 Dec-2016 59.61 Kg Sciegen Pharmaceuticals INC, USA 0.28
3 1701111861 1701113404 l3-Sep-2017 7-0ct-2017 12-Sep-2020 88.48 Kg Sciegen Pharmaceuticals INC, USA 0.47
4 1701112170 1701113405 l8-Sep-2017 7-0ct-2017 l7-Sep-2020 90.92 Kg Sciegen Pharmaceuticals INC, USA 0.15
5 1701112501 1701113406 20-Sep-2017 7-0ct-2017 l9-Sep-2020 93.02 Kg Sciegen Pharmaceuticals INC, USA 1.61
6 1701112056 1701113407 l3-Sep-2017 7-0ct-2017 l2-Sep-2020 88.82 Kg Sciegen Pharmaceuticals INC, USA 0.53
7 1701112558 1701114283 2-0ct-2017 25-0ct-2017 l-Oct-2020 63.76 Kg Sciegen Pharmaceuticals INC, USA 0.6
8 1701112558 1701114284 2-0ct-2017 25-0ct-2017 l-Oct-2020 27.06 Kg Sciegen Pharmaceuticals INC, USA 0.6
9 1701I12559 1701114285 3-0ct-2017 25-0ct-2017 2-0ct-2020 91.82 Kg Sciegen Pharmaceuticals INC, USA 0.45
10 1701112589 1701114286 6-0ct-2017 25-0ct-2017 5-0ct-2020 90.32 Kg Sciegen Pharmaceuticals INC, USA 0.28
11 1701113300 1701114289 7-0ct-2017 25-0ct-2017 6-0ct-2020 91.32 Kg Sciegen Pharmaceuticals INC, USA 0.32
12 1701113301 1701114291 8-0ct-2017 25-0ct-2017 7-0ct-2020 90.12 Kg Sciegen Pharmaceuticals INC, USA 0.32
13 1701113302 1701114708 l7-0ct-2017 30-0ct-2017 l6-0ct-2020 80.82 Kg Sciegen Pharmaceuticals INC, USA 0.85
14 1701113312 1701114709 20-0ct-2017 30-0ct-2017 19 Oct 2020 86.82 Kg Sciegen Pharmaceuticals INC, USA 0.88
15 1701115460 1701117039 23-Nov-2017 2l-Dec-2017 22-Nov-2020 16.72 Kg Sciegen Pharmaceuticals INC, USA 0.31
16 1701115974 1701117040 29-Nov-2017 2l-Dec-2017 28-Nov-2020 91.12 Kg Sciegen Pharmaceuticals INC, USA 0.26
17 1701115460 1701117041 23-Nov-2017 2l-Dec-2017 22-Nov-2020 89.79 Kg Sciegen Pharmaceuticals INC, USA 0.31
18 1701115738 1701117042 24-Nov-2017 21-Dec-2017 23-Nov-2020 90.42 Kg Sciegen Pharmaceuticals INC, USA 0.38
19 1701115739 1701117043 25-Nov-2017 2l-Dec-2017 24-Nov-2020 89.79 Kg Sciegen Pharmaceuticals INC, USA 0.44
20 1701115740 1701117044 26-Nov-2017 2l-Dec-2017 25-Nov-2020 93.42 Kg Sciegen Pharmaceuticals INC, USA 0.34
21 1701115741 1701117045 27-Nov-2017 21-Dec-2017 26-Nov-2020 93.72 Kg Sciegen Pharmaceuticals INC, USA 0.39
22 1701115742 1701117046 28-Nov-2017 21-Dec-2017 27-Nov-2020 93.62 Kg Sciegen Pharmaceuticals INC, USA 0.31

Remark: For Dispatch batch no. 1701114283 & 1701114284, Mother Batch is common 170111255 8

For Dispatch batch no. 1701117039 & 1701117041, Mother Batch is common 1701115460

Total No. of Mother Batches: 20

Total No. of dispatch Batches: 22.

###

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Print

Related

Filed Under: FDA Press Releases

About The FDA

The Food and Drug Administration (FDA) is an agency within the U.S. Department of Health and Human Services. It consists of the Office of the Commissioner and four directorates overseeing the core functions of the agency: Medical Products and Tobacco, Foods and Veterinary Medicine, Global Regulatory Operations and Policy, and Operations.

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Salento Organics Issues Allergy Alert on Undeclared Milk in Dark Chocolate Fruit and Peanut Bites

March 29, 2023 By The FDA

North American Food Distributing Company, Inc. Issues Allergy Alert on Undeclared Soy in 16.9 Fl Oz of Kagome Worcester Sauce and 16.9 Fl Oz of Kagome Chuno Sauce

March 27, 2023 By The FDA

Gilster-Mary Lee Corp. Issues a Recall for Undeclared Milk Allergen in HyVee Hamburger Chili Macaroni Skillet Meal

March 27, 2023 By The FDA

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Kawasaki Motors USA Recalls Engines Sold on Ferris and SCAG Riding Lawn Mowers Due to Burn and Fire Hazards

March 22, 2023 By The CPSC

Burnham Commercial Recalls Natural Gas Boilers Due to Burn Hazard (Recall Alert)

March 22, 2023 By The CPSC

Textron Specialized Vehicles Recalls Arctic Cat Alterra 600 and
Tracker 600 All-Terrain Vehicles (ATVs) Due to Crash Hazard
(Recall Alert)

March 22, 2023 By The CPSC

Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

March 21, 2023 By The FDA

Perfection Bakeries, d/b/a/ Aunt Millie’s Issues Allergy Alert on Undeclared Sesame in “Our Family Hot Dog Buns 8 Ct.”

March 21, 2023 By The FDA

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity

March 21, 2023 By The FDA

Perfection Bakeries, d/b/a/ Aunt Millie’s Issues Allergy Alert on Undeclared Sesame in “Our Family Hot Dog Buns 8 Ct.”

March 21, 2023 By The FDA

Mutual Trading Co., Inc Issues Allergy Alert for Undeclared Soy in Sauces

March 20, 2023 By The FDA

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Salento Organics Issues Allergy Alert on Undeclared Milk in Dark Chocolate Fruit and Peanut Bites
  • North American Food Distributing Company, Inc. Issues Allergy Alert on Undeclared Soy in 16.9 Fl Oz of Kagome Worcester Sauce and 16.9 Fl Oz of Kagome Chuno Sauce
  • Gilster-Mary Lee Corp. Issues a Recall for Undeclared Milk Allergen in HyVee Hamburger Chili Macaroni Skillet Meal
  • Jarman’s Midwest Cleaning Systems, Inc. Issues Voluntary Nationwide Recall of Alcohol Antiseptic 80% Topical Solution Hand Sanitizer Non-sterile Solution and Isopropyl Alcohol Antiseptic 75% Topical Solution Hand Sanitizer Non-sterile Solution Due to Presence of Methanol
  • Second Nature Brands Issues Allergy Alert on Undeclared Wheat in Gluten Free Reese’s Pieces Brownie Brittle
  • Kawasaki Motors USA Recalls Engines Sold on Ferris and SCAG Riding Lawn Mowers Due to Burn and Fire Hazards
  • Burnham Commercial Recalls Natural Gas Boilers Due to Burn Hazard (Recall Alert)
  • Textron Specialized Vehicles Recalls Arctic Cat Alterra 600 and
    Tracker 600 All-Terrain Vehicles (ATVs) Due to Crash Hazard
    (Recall Alert)
  • Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2023 Altrumedia · Terms of Service · Log in